These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27143115)

  • 1. Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38).
    Borroni B; Di Gregorio E; Orsi L; Vaula G; Costanzi C; Tempia F; Mitro N; Caruso D; Manes M; Pinessi L; Padovani A; Brusco A; Boccone L
    Parkinsonism Relat Disord; 2016 Jul; 28():80-6. PubMed ID: 27143115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELOVL5 mutations cause spinocerebellar ataxia 38.
    Di Gregorio E; Borroni B; Giorgio E; Lacerenza D; Ferrero M; Lo Buono N; Ragusa N; Mancini C; Gaussen M; Calcia A; Mitro N; Hoxha E; Mura I; Coviello DA; Moon YA; Tesson C; Vaula G; Couarch P; Orsi L; Duregon E; Papotti MG; Deleuze JF; Imbert J; Costanzi C; Padovani A; Giunti P; Maillet-Vioud M; Durr A; Brice A; Tempia F; Funaro A; Boccone L; Caruso D; Stevanin G; Brusco A
    Am J Hum Genet; 2014 Aug; 95(2):209-17. PubMed ID: 25065913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the administration of Elovl5-dependent fatty acids on a spino-cerebellar ataxia 38 mouse model.
    Balbo I; Montarolo F; Genovese F; Tempia F; Hoxha E
    Behav Brain Funct; 2022 Aug; 18(1):8. PubMed ID: 35933444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension study.
    Manes M; Alberici A; Di Gregorio E; Boccone L; Premi E; Mitro N; Pasolini MP; Pani C; Paghera B; Orsi L; Costanzi C; Ferrero M; Tempia F; Caruso D; Padovani A; Brusco A; Borroni B
    Parkinsonism Relat Disord; 2019 Jun; 63():191-194. PubMed ID: 30862453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCA38 is rare in Mainland China.
    Liu Z; Zeng S; Zeng J; Zhou Y; Zeng X; Jiang H; Shen L; Tang B; Wang J
    J Neurol Sci; 2015 Nov; 358(1-2):333-4. PubMed ID: 26433464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
    Corral-Juan M; Serrano-Munuera C; Rábano A; Cota-González D; Segarra-Roca A; Ispierto L; Cano-Orgaz AT; Adarmes AD; Méndez-Del-Barrio C; Jesús S; Mir P; Volpini V; Alvarez-Ramo R; Sánchez I; Matilla-Dueñas A
    Brain; 2018 Jul; 141(7):1981-1997. PubMed ID: 29939198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38.
    Manes M; Alberici A; Di Gregorio E; Boccone L; Premi E; Mitro N; Pasolini MP; Pani C; Paghera B; Perani D; Orsi L; Costanzi C; Ferrero M; Zoppo A; Tempia F; Caruso D; Grassi M; Padovani A; Brusco A; Borroni B
    Ann Neurol; 2017 Oct; 82(4):615-621. PubMed ID: 28976605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor Deficits and Cerebellar Atrophy in
    Hoxha E; Gabriele RMC; Balbo I; Ravera F; Masante L; Zambelli V; Albergo C; Mitro N; Caruso D; Di Gregorio E; Brusco A; Borroni B; Tempia F
    Front Cell Neurosci; 2017; 11():343. PubMed ID: 29163054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia.
    Marelli C; van de Leemput J; Johnson JO; Tison F; Thauvin-Robinet C; Picard F; Tranchant C; Hernandez DG; Huttin B; Boulliat J; Sangla I; Marescaux C; Brique S; Dollfus H; Arepalli S; Benatru I; Ollagnon E; Forlani S; Hardy J; Stevanin G; Dürr A; Singleton A; Brice A
    Arch Neurol; 2011 May; 68(5):637-43. PubMed ID: 21555639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics of spinocerebellar ataxia 36: a study of 2121 Japanese ataxia patients.
    Sugihara K; Maruyama H; Morino H; Miyamoto R; Ueno H; Matsumoto M; Kaji R; Kitaguchi H; Yukitake M; Higashi Y; Nishinaka K; Oda M; Izumi Y; Kawakami H
    Mov Disord; 2012 Aug; 27(9):1158-63. PubMed ID: 22753339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study.
    Ozaki K; Irioka T; Uchihara T; Yamada A; Nakamura A; Majima T; Igarashi S; Shintaku H; Yakeishi M; Tsuura Y; Okazaki Y; Ishikawa K; Yokota T
    Acta Neuropathol Commun; 2021 Oct; 9(1):172. PubMed ID: 34689836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: A report of two Italian families.
    De Michele G; Lieto M; Galatolo D; Salvatore E; Cocozza S; Barghigiani M; Tessa A; Baldacci J; Pappatà S; Filla A; De Michele G; Santorelli FM
    Parkinsonism Relat Disord; 2019 Aug; 65():91-96. PubMed ID: 31126790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive cerebellar and thalamic degeneration in spinocerebellar ataxia type 10.
    Hernandez-Castillo CR; Diaz R; Vaca-Palomares I; Torres DL; Chirino A; Campos-Romo A; Ochoa A; Rasmussen A; Fernandez-Ruiz J
    Parkinsonism Relat Disord; 2019 Sep; 66():182-188. PubMed ID: 31445906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.
    Hellenbroich Y; Gierga K; Reusche E; Schwinger E; Deller T; de Vos RA; Zühlke C; Rüb U
    J Neural Transm (Vienna); 2006 Jul; 113(7):829-43. PubMed ID: 16362839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 family.
    Palvadeau R; Kaya-Güleç ZE; Şimşir G; Vural A; Öztop-Çakmak Ö; Genç G; Aygün MS; Falay O; Başak AN; Ertan S
    Neurogenetics; 2020 Jan; 21(1):51-58. PubMed ID: 31741143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families.
    Lieto M; Riso V; Galatolo D; De Michele G; Rossi S; Barghigiani M; Cocozza S; Pontillo G; Trovato R; Saccà F; Salvatore E; Tessa A; Filla A; Santorelli FM; De Michele G; Silvestri G
    Eur J Neurol; 2020 Mar; 27(3):498-505. PubMed ID: 31571321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.
    García-Murias M; Quintáns B; Arias M; Seixas AI; Cacheiro P; Tarrío R; Pardo J; Millán MJ; Arias-Rivas S; Blanco-Arias P; Dapena D; Moreira R; Rodríguez-Trelles F; Sequeiros J; Carracedo A; Silveira I; Sobrido MJ
    Brain; 2012 May; 135(Pt 5):1423-35. PubMed ID: 22492559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype.
    Nanetti L; Sarto E; Castaldo A; Magri S; Mongelli A; Rossi Sebastiano D; Canafoglia L; Grisoli M; Malaguti C; Rivieri F; D'Amico MC; Di Bella D; Franceschetti S; Mariotti C; Taroni F
    J Neurol; 2019 Feb; 266(2):378-385. PubMed ID: 30515630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36.
    Aguiar P; Pardo J; Arias M; Quintáns B; Fernández-Prieto M; Martínez-Regueiro R; Pumar JM; Silva-Rodríguez J; Ruibal Á; Sobrido MJ; Cortés J
    Mov Disord; 2017 Feb; 32(2):264-273. PubMed ID: 27862279
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.